Search Results

There are 4955 results for: content related to: Carvedilol, a new nonselective beta-blocker with intrinsic anti-alpha 1 -adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis

  1. Carvedilol: A Novel Cardiovascular Drug with Multiple Actions

    Cardiovascular Drug Reviews

    Volume 10, Issue 2, June 1992, Pages: 127–157, Robert R. Ruffolo Jr., Duane A. Boyle, David P. Brooks, Giora Z. Feuerstein, Robert P. Venuti, Mary Ann Lukas and George Poste

    Version of Record online : 2 APR 2007, DOI: 10.1111/j.1527-3466.1992.tb00242.x

  2. Carvedilol: A Novel Multiple Action Antihypertensive Drug that Provides Major Organ Protection

    Cardiovascular Drug Reviews

    Volume 12, Issue 2, June 1994, Pages: 85–104, Giora Feuerstein, Tian-Li Yue, XinLiang Ma and Robert Ruffolo Jr.

    Version of Record online : 2 APR 2007, DOI: 10.1111/j.1527-3466.1994.tb00285.x

  3. You have free access to this content
    Carvedilol: Molecular and Cellular Basis for Its Multifaceted Therapeutic Potential

    Cardiovascular Drug Reviews

    Volume 19, Issue 2, June 2001, Pages: 152–171, Jianhua Cheng, Kaichiro Kamiya and Itsuo Kodama

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3466.2001.tb00061.x

  4. Mechanism of carvedilol-induced block of delayed rectifier K+ current in the NG108-15 neuronal cell line

    Drug Development Research

    Volume 58, Issue 2, February 2003, Pages: 196–208, Chun-Peng Liu, Hung-Ting Chiang, Chung-Ren Jan and Sheng-Nan Wu

    Version of Record online : 27 MAR 2003, DOI: 10.1002/ddr.10165

  5. Carvedilol

    Cardiovascular Drug Reviews

    Volume 5, Issue 1, March 1987, Pages: 135–153, Erika von Möllendorff, Gisbert Sponer, Klaus Strein, Wolfgang Bartsch, Bernd Müller-Beckmann, Günter Neugebauer, Harald Czerwek, Gerd Bode and Erhard Schnurr

    Version of Record online : 2 APR 2007, DOI: 10.1111/j.1527-3466.1987.tb00506.x

  6. Steady-State Pharmacokinetics of Carvedilol and Its Enantiomers in Patients with Congestive Heart Failure

    The Journal of Clinical Pharmacology

    Volume 40, Issue 8, August 2000, Pages: 844–853, Dr. David Tenero, Dr. Steven Boike, Dr. Duane Boyle, Dr. Bernard Ilson, Dr. Henry F. Fesniak, Dr. Susan Brozena and Dr. Diane Jorkasky

    Version of Record online : 8 MAR 2013, DOI: 10.1177/00912700022009576

  7. Ethanol Does Not Alter the Pharmacokinetic Profile of the Controlled-release Formulation of Carvedilol

    The Journal of Clinical Pharmacology

    Volume 47, Issue 11, November 2007, Pages: 1358–1365, Dr Linda S. Henderson, Dr David M. Tenero, Ms Andrea M. Campanile, Charlotte A. Baidoo and Dr Theodore M. Danoff

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007307244

  8. Carvedilol promotes neurological function, reduces bone loss and attenuates cell damage after acute spinal cord injury in rats

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 2, February 2015, Pages: 202–212, Da Liu, Ying Huang, Bin Li, Changqing Jia, Feng Liang and Qin Fu

    Version of Record online : 12 JAN 2015, DOI: 10.1111/1440-1681.12345

  9. Analysis of carvedilol enantiomers in human plasma using chiral stationary phase column and liquid chromatography with tandem mass spectrometry


    Volume 24, Issue 3, March 2012, Pages: 209–214, Josiane Cristófani Poggi, Flávia Garcez Da Silva, Eduardo Barbosa Coelho, Maria Paula Marques, Carlo Bertucci and Vera Lucia Lanchote

    Version of Record online : 24 JAN 2012, DOI: 10.1002/chir.21984

  10. You have free access to this content
    Modulation of K2P2.1 and K2P10.1 K+ channel sensitivity to carvedilol by alternative mRNA translation initiation

    British Journal of Pharmacology

    Volume 171, Issue 23, December 2014, Pages: 5182–5194, J Kisselbach, C Seyler, P A Schweizer, R Gerstberger, R Becker, H A Katus and D Thomas

    Version of Record online : 28 AUG 2014, DOI: 10.1111/bph.12596

  11. Evaluation of Carvedilol for the Treatment of Portal Hypertension

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 1, January 2004, Pages: 94–104, Brian A. Hemstreet

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.

  12. Critical Differences Among Beta-Adrenoreceptor Antagonists in Myocardial Failure: Debating the MERIT of COMET

    The Journal of Clinical Pharmacology

    Volume 45, Issue 1, January 2005, Pages: 6–24, Dr Brian F. McBride and Dr C. Michael White

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270004269841

  13. You have free access to this content
    Carvedilol in the failing heart

    Clinical Cardiology

    Volume 24, Issue 12, December 2001, Pages: 757–766, William L. Lombardi and Edward M. Gilbert

    Version of Record online : 3 FEB 2009, DOI: 10.1002/clc.4960241202

  14. You have free access to this content
    Oxidative Status, Inflammation, and Postoperative Atrial Fibrillation With Metoprolol vs Carvedilol or Carvedilol Plus N-Acetyl Cysteine Treatment

    Clinical Cardiology

    Volume 37, Issue 5, May 2014, Pages: 300–306, Mehmet Ozaydin, Oktay Peker, Dogan Erdogan, Selahaddin Akcay, Habil Yucel, Atilla Icli, Betul M. Ceyhan, Recep Sutcu, Bayram A. Uysal, Ercan Varol, Abdullah Dogan and Huseyin Okutan

    Version of Record online : 29 JAN 2014, DOI: 10.1002/clc.22249

  15. Clinical pharmacology of carvedilol in normal volunteers

    Clinical Pharmacology & Therapeutics

    Volume 41, Issue 1, January 1987, Pages: 31–44, Luigi X Cubeddu, Nery Fuenmayor, France Varin, Victor G Villagra, Romulo E Colindres and J Robert Powell

    Version of Record online : 15 JAN 1987, DOI: 10.1038/clpt.1987.6

  16. You have free access to this content
    Carvedilol's antiarrhythmic properties: Therapeutic implications in patients with left ventricular dysfunction

    Clinical Cardiology

    Volume 28, Issue 4, April 2005, Pages: 165–173, Gerald V. Naccarelli and Mary Ann Lukas

    Version of Record online : 5 DEC 2006, DOI: 10.1002/clc.4960280403

  17. You have free access to this content
    Carvedilol targets human K2P3.1 (TASK1) K+ leak channels

    British Journal of Pharmacology

    Volume 163, Issue 5, July 2011, Pages: 1099–1110, K Staudacher, I Staudacher, E Ficker, C Seyler, J Gierten, J Kisselbach, A-K Rahm, K Trappe, PA Schweizer, R Becker, HA Katus and D Thomas

    Version of Record online : 8 JUN 2011, DOI: 10.1111/j.1476-5381.2011.01319.x

  18. You have free access to this content
    Switching Between Beta Blockers in Heart Failure Patients: Rationale and Practical Considerations

    Congestive Heart Failure

    Volume 9, Issue 5, September/October 2003, Pages: 271–278, William T. Abraham

    Version of Record online : 8 JUN 2007, DOI: 10.1111/j.1527-5299.2003.02001.x

  19. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol

    Fundamental & Clinical Pharmacology

    Volume 5, Issue 1, February 1991, Pages: 25–38, AJ Nichols, M. Gellai and RR Ruffolo Jr

    Version of Record online : 26 AUG 2009, DOI: 10.1111/j.1472-8206.1991.tb00698.x

  20. Population pharmacokinetics of carvedilol in patients with congestive heart failure

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 8, August 2013, Pages: 2851–2858, Valentina N. Nikolic, Slobodan M. Jankovic, Radmila Velickovic-Radovanović, Svetlana Apostolović, Dragana Stanojevic, Slavoljub Zivanovic, Nikola Stefanovic, Srdjan Pesic, Tatjana Jevtovic-Stoimenov, Janko Djuric, Veroljub Markovic and Jasmina R. Milovanovic

    Version of Record online : 31 MAY 2013, DOI: 10.1002/jps.23626